So firstly the no case, and Rob Spiera takes up the case, dictated by the electronic coin toss. No-one disagrees that we need steroid-sparing options, or that IL-6Ri work in PMR and GCA. But it’s the strategy questions which remain in play: #ACR23 @RheumNow https://t.co/I2QDU7l6DE